{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:24:27Z","timestamp":1789867467510,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ctrv.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T01:18:23Z","timestamp":1385601503000},"page":"685-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score"],"prefix":"10.1016","volume":"40","author":[{"given":"Euan","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2013.11.007_b0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctrv.2013.11.007_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N","article-title":"The role of cytokines in cancer cachexia","volume":"19","author":"Argil\u00e9s","year":"1999","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ctrv.2013.11.007_b0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","article-title":"The immediate causes of death in cancer","volume":"184","author":"Warren","year":"1932","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ctrv.2013.11.007_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ctrv.2013.11.007_b0030","first-page":"157","article-title":"Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative\/supportive care","volume":"5","author":"MacDonald","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0035","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","article-title":"Increased resting energy-expenditure and weight-loss are related to a systemic inflammatory response in lung-cancer patients","volume":"13","author":"Vandenbrekel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer","volume":"67","author":"McMillan","year":"2008","journal-title":"P Nutr Soc"},{"key":"10.1016\/j.ctrv.2013.11.007_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ctrv.2013.11.007_b0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tem.2012.10.006","article-title":"Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem","volume":"24","author":"Tsoli","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2013.11.007_b0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hed.23023","article-title":"Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view","volume":"35","author":"Kubrak","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2013.11.007_b0060","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2013.11.007_b0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/bjs.1800810727","article-title":"Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer","volume":"81","author":"McMillan","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctrv.2013.11.007_b0070","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","article-title":"Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer","volume":"80","author":"Gupta","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0075","first-page":"290","article-title":"Weight and body composition changes during R-CHOP chemotherapy in patients with non-Hodgkin\u2019s lymphoma and their impact on dose intensity and toxicity","volume":"15","author":"Stanisavljevic","year":"2010","journal-title":"J BUON"},{"issue":"7\u20138","key":"10.1016\/j.ctrv.2013.11.007_b0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0899-9007(02)00821-3","article-title":"Measurement of body fat by dual-energy X-ray absorptiometry and bioimpedance analysis in men with prostate cancer","volume":"18","author":"Smith","year":"2002","journal-title":"Nutrition"},{"key":"10.1016\/j.ctrv.2013.11.007_b0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","article-title":"Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine","volume":"183","author":"May","year":"2002","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctrv.2013.11.007_b0090","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1139\/h2012-079","article-title":"A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer","volume":"37","author":"Di Sebastiano","year":"2012","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.ctrv.2013.11.007_b0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SPC.0b013e328331124a","article-title":"The emerging role of computerized tomography in assessing cancer cachexia","volume":"3","author":"Prado","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ctrv.2013.11.007_b0105","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.ctrv.2013.11.007_b0110","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2013.11.007_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","article-title":"An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity","volume":"67","author":"Prado","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0120","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.ctrv.2013.11.007_b0130","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ctrv.2013.11.007_b0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","article-title":"Sarcopenia and mortality after liver transplantation","volume":"211","author":"Englesbe","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ctrv.2013.11.007_b0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1477-2574.2011.00301.x","article-title":"Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis","volume":"13","author":"Peng","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.ctrv.2013.11.007_b0150","doi-asserted-by":"crossref","first-page":"e41883","DOI":"10.1371\/journal.pone.0041883","article-title":"The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer","volume":"7","author":"Richards","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2013.11.007_b0155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0160","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The Use of the Nitrogen Mustards in the Palliative Treatment of Carcinoma - with Particular Reference to Bronchogenic Carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0170","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jjco\/hys124","article-title":"Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer","volume":"42","author":"Hwang","year":"2012","journal-title":"Jpn J Clin Oncol"},{"issue":"8 Pt 2","key":"10.1016\/j.ctrv.2013.11.007_b0175","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1111\/j.1440-1746.2007.05105.x","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer","volume":"23","author":"Crumley","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ctrv.2013.11.007_b0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12032-013-0656-y","article-title":"Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies","volume":"30","author":"Dr\u00e9anic","year":"2013","journal-title":"Med Oncol"},{"issue":"19","key":"10.1016\/j.ctrv.2013.11.007_b0185","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ctrv.2013.11.007_b0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0195","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ajcn\/82.5.1074","article-title":"Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents","volume":"82","author":"Wilson","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC352_5","article-title":"Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer","volume":"35","author":"O\u2019Gorman","year":"1999","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_h0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1079\/BJN19950056","article-title":"The reproducibility of subjective appetite scores","volume":"73","author":"Raben","year":"1995","journal-title":"Br J Nutr"},{"issue":"2","key":"10.1016\/j.ctrv.2013.11.007_h0210","first-page":"283","volume":"74","author":"Raben","year":"1995","journal-title":"Erratum in: Br J Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0210","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jech.54.8.611","article-title":"The problem of accuracy in dietary surveys. Analysis of the over 65 UK National Diet and Nutrition Survey","volume":"54","author":"Cook","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ctrv.2013.11.007_b0215","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-8223(93)91820-G","article-title":"Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake","volume":"93","author":"Black","year":"1993","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.ctrv.2013.11.007_b0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1998.0398","article-title":"Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer","volume":"11","author":"Mart\u00edn","year":"1999","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.ctrv.2013.11.007_b0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01635589809514722","article-title":"Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients","volume":"32","author":"O\u2019Gorman","year":"1998","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6604828","article-title":"The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer","volume":"100","author":"Deans","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00520-009-0681-8","article-title":"Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment","volume":"18","author":"Capuano","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0240","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2013.11.007_b0245","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.bjc.6604248","article-title":"The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer","volume":"98","author":"McKernan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0250","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00520-012-1569-6","article-title":"Health-related quality of life and inflammatory markers in malignant pleural mesothelioma","volume":"21","author":"Kao","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0255","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients","volume":"21","author":"Wallengren","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0260","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpainsymman.2011.03.025","article-title":"Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set","volume":"43","author":"Minton","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ctrv.2013.11.007_b0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejca.2008.09.010","article-title":"A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome","volume":"45","author":"Alexander","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0325","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2013.11.007_b0270","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0275","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctrv.2013.11.007_b0285","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0148607108325076","article-title":"Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group","volume":"33","author":"Bozzetti","year":"2009","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0290","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Hustead DS; Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCO.0b013e328352a895","article-title":"Terminology in cancer cachexia: importance and status","volume":"15","author":"MacDonald","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ctrv.2013.11.007_b0300","series-title":"IDF Diabetes Atlas, fifth ed","author":"DiabetesFederation","year":"2011"},{"key":"10.1016\/j.ctrv.2013.11.007_b0305","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1017\/S0007114512004527","article-title":"Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks","volume":"109","author":"van der Meij","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ctrv.2013.11.007_b0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2011.09.012","article-title":"Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system","volume":"76","author":"Op den Kamp","year":"2012","journal-title":"Lung cancer"},{"key":"10.1016\/j.ctrv.2013.11.007_b0315","first-page":"171","article-title":"Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun. 2013, 30(Suppl), pp. S58\u201367.64. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Irwin","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ctrv.2013.11.007_b0320","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ctrv.2013.11.007_b0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Thoresen","year":"2013","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.ctrv.2013.11.007_b0335","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.nut.2012.09.016","article-title":"Relationship between nutritional status and the Glasgow prognostic score in patients with colorectal cancer","volume":"29","author":"Maur\u00edcio","year":"2013","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.ctrv.2013.11.007_b0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2013.11.007_b0345","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bjc.2013.418","article-title":"Cancer and systemic inflammation: stage the tumour and stage the host","volume":"109","author":"McMillan","year":"2013","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.ctrv.2013.11.007_b0350","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/bjs.9163","article-title":"Preoperative indicators of the systemic inflammatory response in the treatment of patients with gastrointestinal cancer","volume":"100","author":"McMillan","year":"2013","journal-title":"Br J Surg"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737213002600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737213002600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T01:48:35Z","timestamp":1564883315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737213002600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0305737213002600"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2013.11.007","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}